ESC 365 - CDK4/6 inhibitor ribociclib induces cardiotoxicity in dynamic engineered heart tissues, mitigated by E2F1 overexpression

HFA Premium Access

CDK4/6 inhibitor ribociclib induces cardiotoxicity in dynamic engineered heart tissues, mitigated by E2F1 overexpression

Session: Basic science

Topic: Stem Cells, Cell Cycle, Cell Senescence, Cell Death

Speaker: Mr I. Dias (Groningen, NL)

Event: Heart Failure 2024

Congress Presentation

About the speaker

Mr Itamar Dias

University Medical Centre Groningen, Groningen (Netherlands (The))

0 follower

4 more presentations in this session

Unravelling the diversity of cholinesterases in the murine heart as an essential prerequisite for the use of cholinesterase inhibitors in the treatment of heart failure

Speaker: Associate Professor A. Hrabovska (Bratislava, SK)

Cellular phenotyping of structural and functional changes in atrial myopathy

Speaker: Doctor J. Huettemeister (Berlin, DE)

Non-dilated left ventricular cardiomyopathy with arrhythmias is caused by the nonsense founder variant DSP:c.3793G>T in Slovenian patients

Speaker: Ms N. Vodnjov (Ljubljana, SI)

Effect of empagliflozin with or without sacubitril/valsartan on the lipoprotein, glycoprotein and lipid profile in a porcine model of myocardial infarction

Speaker: Miss D. Martinez-Falguera (Badalona, ES)

Access the full session

Basic science

Speakers: Mr I. Dias, Associate Professor A. Hrabovska, Doctor J. Huettemeister, Ms N. Vodnjov, Miss D. Martinez-Falguera

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources